HKSE - Delayed Quote HKD

Medlive Technology Co., Ltd. (2192.HK)

Compare
8.570
+0.020
+(0.23%)
As of 2:29:56 PM GMT+8. Market Open.
Loading Chart for 2192.HK
DELL
  • Previous Close 8.550
  • Open 8.570
  • Bid 8.540 x --
  • Ask 8.570 x --
  • Day's Range 8.520 - 8.780
  • 52 Week Range 5.850 - 10.640
  • Volume 180,000
  • Avg. Volume 805,989
  • Market Cap (intraday) 6.281B
  • Beta (5Y Monthly) 0.66
  • PE Ratio (TTM) 20.40
  • EPS (TTM) 0.420
  • Earnings Date --
  • Forward Dividend & Yield 0.27 (3.15%)
  • Ex-Dividend Date Oct 22, 2024
  • 1y Target Est 10.84

Medlive Technology Co., Ltd. operates an online professional physician platform in Mainland China and internationally. The company's precision marketing and corporate solution provides digital marketing, digital detailing, digital marketing consultation, digital content creation, application software development, and other relevant services. Its medical knowledge solution offers medical education and clinical decision support, including licensing software to physicians, other registered users, such as other healthcare professionals and pharmaceutical companies. The company's intelligent patient management solution provides single disease management services, including diseases knowledge dissemination and treatment compliance monitoring management; patient education services comprising content development, application software development, and other related services; and chronic disease management services for Parkinson's lymphoma, stroke and diabetes, and breast, lung, and ovarian cancer. In addition, it is involved in research and development services; internet hospital services; publication and planning services for medicine guidelines and medical consensus; organizing medical exhibition conferences; provision of medical services; and research services to pharmaceutical companies. The company was formerly known as Kingyee Co., Limited and changed its name to Medlive Technology Co., Ltd. in 2021. The company was founded in 1996 and is headquartered in Beijing, China.

www.medlive.cn

746

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 2192.HK

View More

Performance Overview: 2192.HK

Trailing total returns as of 1/20/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

2192.HK
14.21%
HANG SENG INDEX
0.65%

1-Year Return

2192.HK
32.22%
HANG SENG INDEX
30.07%

3-Year Return

2192.HK
54.64%
HANG SENG INDEX
17.47%

5-Year Return

2192.HK
70.35%
HANG SENG INDEX
31.47%

Compare To: 2192.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 2192.HK

View More

Valuation Measures

As of 9/19/2024
  • Market Cap

    6.27B

  • Enterprise Value

    2.18B

  • Trailing P/E

    20.42

  • Forward P/E

    17.45

  • PEG Ratio (5yr expected)

    1.75

  • Price/Sales (ttm)

    12.29

  • Price/Book (mrq)

    1.26

  • Enterprise Value/Revenue

    4.26

  • Enterprise Value/EBITDA

    6.42

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    60.24%

  • Return on Assets (ttm)

    1.26%

  • Return on Equity (ttm)

    6.46%

  • Revenue (ttm)

    481.94M

  • Net Income Avi to Common (ttm)

    290.3M

  • Diluted EPS (ttm)

    0.420

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.86B

  • Total Debt/Equity (mrq)

    0.34%

  • Levered Free Cash Flow (ttm)

    -45.83M

Research Analysis: 2192.HK

View More

People Also Watch